Doctors Hope Better Blood Thinners Are On The Horizon
Doctors are hopeful three new experimental drugs will make treatment more accessible for millions of people at risk of lethal blood clots.
Two million patients currently use Coumadin, also known as warfarin, that causes an array of side effects and restrictions. The goal of the new drugs is to provide an alternative.
The first target is a pill option for people who now require daily blood-thinning shots for weeks after knee or hip replacement surgery.